DiagnaMed Holdings Corp. (TSE:DMED) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
DiagnaMed Holdings Corp. is leveraging its BRAIN AGE Brain Health AI Platform to study the effects of weight loss drugs, like Semaglutide, on brain function. The platform aims to identify potential brain health issues and provide insights into cognitive performance during treatment. This could lead to personalized approaches for maintaining or enhancing brain health amid the rising global market for obesity drugs.
For further insights into TSE:DMED stock, check out TipRanks’ Stock Analysis page.